Lucas Basler

442 total citations
19 papers, 300 citations indexed

About

Lucas Basler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lucas Basler has authored 19 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lucas Basler's work include Cancer Immunotherapy and Biomarkers (10 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Immunotherapy and Immune Responses (5 papers). Lucas Basler is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Immunotherapy and Immune Responses (5 papers). Lucas Basler collaborates with scholars based in Switzerland, Germany and Canada. Lucas Basler's co-authors include Matthias Gückenberger, Stephanie Tanadini‐Lang, Stephanie Kroeze, Ken Kudura, Stefanie Ehrbar, Reinhard Dummer, Robert Förster, Marta Bogowicz, Diem Vuong and Matea Pavic and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lucas Basler

19 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas Basler Switzerland 11 173 136 125 49 32 19 300
Pierre-Antoine Laurent France 6 220 1.3× 79 0.6× 70 0.6× 122 2.5× 27 0.8× 13 319
Andrea D’Aviero Italy 10 111 0.6× 104 0.8× 83 0.7× 29 0.6× 63 2.0× 42 307
Alexander M.A. van der Wiel Netherlands 5 111 0.6× 247 1.8× 105 0.8× 35 0.7× 22 0.7× 6 381
C. Chira France 9 130 0.8× 86 0.6× 194 1.6× 30 0.6× 117 3.7× 34 333
Antonio Stefanelli Italy 9 102 0.6× 64 0.5× 130 1.0× 16 0.3× 40 1.3× 38 287
Martina Vrankar Slovenia 12 230 1.3× 83 0.6× 217 1.7× 36 0.7× 7 0.2× 21 347
Melek Tuğçe Yılmaz Türkiye 7 243 1.4× 95 0.7× 210 1.7× 12 0.2× 30 0.9× 27 365
Beata Sas-Korczyńska Poland 12 223 1.3× 126 0.9× 203 1.6× 19 0.4× 36 1.1× 60 488
Honghai Dai China 11 136 0.8× 167 1.2× 236 1.9× 15 0.3× 16 0.5× 14 355
Catherine Dubos‐Arvis France 8 310 1.8× 104 0.8× 348 2.8× 27 0.6× 12 0.4× 11 476

Countries citing papers authored by Lucas Basler

Since Specialization
Citations

This map shows the geographic impact of Lucas Basler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Basler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Basler more than expected).

Fields of papers citing papers by Lucas Basler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Basler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Basler. The network helps show where Lucas Basler may publish in the future.

Co-authorship network of co-authors of Lucas Basler

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Basler. A scholar is included among the top collaborators of Lucas Basler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Basler. Lucas Basler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gabryś, Hubert S., Lucas Basler, Sabrina A. Hogan, et al.. (2022). Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition. Frontiers in Oncology. 12. 830627–830627. 4 indexed citations
2.
Schröder, Christina, Claudio De Angelis, Lucas Basler, et al.. (2022). NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors. International Journal of Radiation Oncology*Biology*Physics. 113(2). 448–455. 6 indexed citations
3.
Gabryś, Hubert S., Lucas Basler, Sabrina A. Hogan, et al.. (2022). PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Frontiers in Oncology. 12. 977822–977822. 5 indexed citations
4.
Kudura, Ken, et al.. (2022). Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. Cancers. 14(20). 5145–5145. 13 indexed citations
5.
Kudura, Ken, et al.. (2022). Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients. Biomedicines. 10(9). 2135–2135. 7 indexed citations
6.
Vuong, Diem, Marta Bogowicz, Martin Hüllner, et al.. (2021). Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging. EJNMMI Research. 11(1). 79–79. 12 indexed citations
7.
Bogowicz, Marta, Matea Pavic, Oliver Riesterer, et al.. (2021). Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes. Frontiers in Oncology. 11. 664304–664304. 16 indexed citations
8.
Kudura, Ken, Florentia Dimitriou, Daniela Mihic‐Probst, et al.. (2021). Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients. Diagnostics. 11(5). 883–883. 4 indexed citations
9.
Angelis, C. De, et al.. (2021). NTCP Modelling for High Grade Temporal Radio-Necrosis in a Large Cohort of Patients Receiving PBS Proton Therapy for Skull Base and Head and Neck Tumors. International Journal of Radiation Oncology*Biology*Physics. 111(3). e586–e587. 1 indexed citations
10.
Kudura, Ken, Florentia Dimitriou, Lucas Basler, et al.. (2021). Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers. 13(15). 3830–3830. 14 indexed citations
11.
Basler, Lucas, Hubert S. Gabryś, Sabrina A. Hogan, et al.. (2020). Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition. Clinical Cancer Research. 26(16). 4414–4425. 69 indexed citations
12.
Schröder, Christina, André Buchali, Paul Windisch, et al.. (2020). Impact of Low-Dose Irradiation of the Lung and Heart on Toxicity and Pulmonary Function Parameters after Thoracic Radiotherapy. Cancers. 13(1). 22–22. 6 indexed citations
13.
Sung, Wonmo, Clemens Grassberger, Aimee L. McNamara, et al.. (2020). A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy. Radiotherapy and Oncology. 151. 73–81. 33 indexed citations
14.
Basler, Lucas, Christina Schröder, Alessandra Bolsi, et al.. (2020). Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy. Radiation Oncology. 15(1). 266–266. 13 indexed citations
15.
Kroeze, Stephanie, Corinna Fritz, Lucas Basler, et al.. (2019). Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries. Strahlentherapie und Onkologie. 195(3). 199–206. 15 indexed citations
16.
Basler, Lucas, Hubert S. Gabryś, Sabrina A. Hogan, et al.. (2019). Delta-radiomics for prediction of pseudoprogression in malignant melanoma treated with immune checkpoint inhibition.. Journal of Clinical Oncology. 37(15_suppl). 9575–9575. 1 indexed citations
17.
Basler, Lucas, Regina Heidenreich, Mariola Fotin‐Mleczek, et al.. (2018). Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model. Cancer Immunology Immunotherapy. 67(4). 653–662. 10 indexed citations
18.
Basler, Lucas, Nicolaus Andratschke, Stefanie Ehrbar, Matthias Gückenberger, & Stephanie Tanadini‐Lang. (2018). Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study. Radiation Oncology. 13(1). 10–10. 32 indexed citations
19.
Basler, Lucas, Stephanie Kroeze, & Matthias Gückenberger. (2017). SBRT for oligoprogressive oncogene addicted NSCLC. Lung Cancer. 106. 50–57. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre-Antoine Laurent Breakdown of academic impact, for papers by Andrea D’Aviero Breakdown of academic impact, for papers by Alexander M.A. van der Wiel Breakdown of academic impact, for papers by C. Chira Breakdown of academic impact, for papers by Antonio Stefanelli Breakdown of academic impact, for papers by Martina Vrankar Breakdown of academic impact, for papers by Melek Tuğçe Yılmaz Breakdown of academic impact, for papers by Beata Sas-Korczyńska Breakdown of academic impact, for papers by Honghai Dai Breakdown of academic impact, for papers by Catherine Dubos‐Arvis
Rankless by CCL
2026